An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

According to the Mayo Clinic, the BRCA test is a blood test that uses DNA analysis to identify harmful changes in one of the two breast cancer susceptibility genes (BRCA1 and BRCA2). Those who have ...

Federal regulators on Tuesday let 23andMe become the first to market a test for three inherited BRCA gene mutations directly to consumers - no doctor's prescription needed. But there are lots of ...

Breast and ovarian cancer typically aren't things you worry about in your 20s and 30s. However, as many as 415,000 U.S. women have a BRCA gene mutation, which increases risk for these cancers, ...

Breast cancer survivor Christina Applegate announced that she had her ovaries and fallopian tubes removed because she has the BRCA1 mutation — should you get tested? In 2008, Christina Applegate was ...

In May 2013, nearly 20 years after the discovery that mutations on the BRCA1 and BRCA2 genes could lead to a higher risk of breast and ovarian cancer, A-list Hollywood actress Angelina Jolie garnered ...

More women may benefit from gene testing for hereditary breast or ovarian cancer, especially if they’ve already survived cancer once, according to new recommendations from experts in preventive ...

When we hear about gene mutations like the BRCA gene, we think of breast cancer screening in women. But, researchers say men are also at risk for the carrying the gene, which is linked to other ...

BOSTON (CBS) - For the first time the FDA has granted permission to market a direct-to-consumer genetic test to check for BRCA mutations that are associated with breast and ovarian cancer. 23andMe, a ...

You’ve probably heard of the BRCA gene mutations, perhaps thanks to celebs like Angelina Jolie and Christina Applegate. You might have even considered getting tested yourself: The proportion of women ...

Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer, the agency announced on Tuesday. The test for the BRCA1 and ...

When the FDA approved 23andMe’s direct-to-consumer test for some BRCA1/BRCA2 gene mutations on March 6, it did so with caveats. The test, which will be wrapped into a larger health-risk test offered ...